Diagnosis and biomarkers of predementia in Alzheimer's disease

Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease

(2010) K.B. Walhovd et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Cross-cultural Adaptation, Reliability and Validity of the DAFS-R in a Sample of Brazilian Older Adults

(2010) F. S. Pereira et al.   ARCHIVES OF CLINICAL NEUROPSYCHOLOGY

Correlation of Longitudinal Cerebrospinal Fluid Biomarkers With Cognitive Decline in Healthy Older Adults

(2010) Erik Stomrud et al.   ARCHIVES OF NEUROLOGY

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

(2010) Niklas Mattsson et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

(2010) Hiroaki Fukumoto et al.   FASEB JOURNAL

Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement

(2010) FERNANDA SPEGGIORIN PEREIRA et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Alzheimer's disease: strategies for disease modification

(2010) Martin Citron   NATURE REVIEWS DRUG DISCOVERY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

(2010) S. M. Resnick et al.   NEUROLOGY

Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment

(2010) Orestes V. Forlenza et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies

(2009) A. J. Mitchell et al.   ACTA PSYCHIATRICA SCANDINAVICA

Mild Cognitive Impairment and Everyday Function: Evidence of Reduced Speed in Performing Instrumental Activities of Daily Living

(2009) Virginia G. Wadley et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease

(2009) John C. Morris et al.   ARCHIVES OF NEUROLOGY

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

(2009) Tero Tapiola et al.   ARCHIVES OF NEUROLOGY

Short-term memory binding deficits in Alzheimer's disease

(2009) M. A. Parra et al.   BRAIN

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index

(2009) C. Davatzikos et al.   BRAIN

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

(2009) Clifford R. Jack et al.   BRAIN

Biomarkers: Principles, Policies, and Practice

(2009) JA Wagner   CLINICAL PHARMACOLOGY & THERAPEUTICS

Diagnosis of Mild Cognitive Impairment Revisited after One Year

(2009) Breno Satler Diniz et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Characteristic Profiles of Instrumental Activities of Daily Living in Different Subtypes of Mild Cognitive Impairment

(2009) Kyung Ran Kim et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

(2009) Anne M. Fagan et al.   EMBO Molecular Medicine

Functional Abilities in Older Adults with Mild Cognitive Impairment

(2009) Catherine L. Burton et al.   GERONTOLOGY

Diagnostic transitions in mild cognitive impairment subtypes

(2009) Orestes Vicente Forlenza et al.   INTERNATIONAL PSYCHOGERIATRICS

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid

(2009) Hillevi Englund et al.   Neurodegenerative Diseases

Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study

(2009) A. Okello et al.   NEUROLOGY

Fibrillar amyloid-  burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

(2009) E. M. Reiman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil

(2009) Izabella Dutra de Abreu et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Worldwide variation in the doubling time of Alzheimer's disease incidence rates

(2008) Kathryn Ziegler-Graham et al.   Alzheimers & Dementia

Characterization of Activities of Daily Living in Individuals With Mild Cognitive Impairment

(2008) Angela L. Jefferson et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Detection of prodromal Alzheimer's disease

(2008) James A. Mortimer et al.   ANNALS OF NEUROLOGY

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly

(2008) Howard Jay Aizenstein et al.   ARCHIVES OF NEUROLOGY

Mild cognitive impairment: a concept ready to move on?

(2008) Orestes V Forlenza et al.   CURRENT OPINION IN PSYCHIATRY

Principal component analysis of FDG PET in amnestic MCI

(2008) Flavio Nobili et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Voxel-based morphometry in Alzheimer’s disease

(2008) Geraldo F Busatto et al.   Expert Review of Neurotherapeutics

Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment

(2008) F. S. Pereira et al.   INTERNATIONAL PSYCHOGERIATRICS

Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

(2008) Peter T. Nelson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

(2008) L. Mosconi et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

(2008) Christopher C Rowe et al.   LANCET NEUROLOGY

Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease

(2008) V.L. Villemagne et al.   NEUROPSYCHOLOGIA

Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

(2008) Breno S. O. Diniz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

β-amyloid burden is not associated with rates of brain atrophy

(2007) Keith A. Josephs et al.   ANNALS OF NEUROLOGY

PET imaging of amyloid deposition in patients with mild cognitive impairment

(2007) Anton Forsberg et al.   NEUROBIOLOGY OF AGING

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

(2007) Oskar Hansson et al.   NEUROBIOLOGY OF AGING

MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study

(2006) Tero Tapiola et al.   NEUROBIOLOGY OF AGING